Healthcare >> Sector Roundtables >> December 13, 2004
SURAJ KALIA joined Northland Securities, Inc., in March 2003 and follows
life sciences and technology companies. Prior to Northland, Mr. Kalia
worked in the Business Development Group at Entegris, Inc., where he was
responsible for analyzing potential acquisition targets, strategic and
financial valuation, due diligence, deal structuring and management
interviews. Prior to moving to Minneapolis to join Entegris, he worked
as an analyst at a boutique broker-dealer in New Jersey, where he wrote
and modeled numerous companies in the healthcare sector. Prior to moving
to the US, he worked for 4 years in India at Tata Capital as an
Investment Banking Analyst. Mr. Kalia has over 10 years of work
experience in equity research, M&A and engineering. He holds a
Bachelor's degree in Chemical Engineering from the prestigious Indian
Institute of Technology in Bombay, India. He received his Master's
degree in Chemical Engineering at Stevens Institute of Technology, New
Jersey and his MBA from the University of St. Thomas, Minneapolis, where
he currently serves an Adjunct Professor of Finance for the MBA
curriculum. He is a member of the Twin Cities Society of Security
Analysts and the Association for Investment Management and Research
(AIMR) and adheres to AIMR's Code of Ethics and Standards of
Professional Conduct as a charterholder of the Chartered Financial
Analyst designation. Profile
ELI KAMMERMAN covers the medical devices industry as a Senior Analyst at
Cathay Financial LLC. He began following the industry in 1994, after
following the biotechnology sector for two years. As an Analyst, Mr.
Kammerman has worked at Merrill Lynch, Salomon Brothers, and Raymond
James. He was employed for 11 years in the biotech, diagnostics and
pharmaceutical industries in production and marketing positions. Mr.
Kammerman holds a BA in Biology from Boston University and attended the
Technology Management program at the University of Maryland. Profile
ANTHONY V. VENDETTI has been a Senior Healthcare Analyst on Wall Street
for more than 10 years and follows the medical device, healthcare
information technology and services industries. Prior to joining Maxim
Group, LLC, Mr. Vendetti was a Senior Healthcare Analyst at Gruntal, UBS
Securities and Ladenburg Thalmann. Mr. Vendetti also worked for three
years in the healthcare industry at CIGNA, ultimately as a Senior
Healthcare Analyst in the managed care division. His responsibilities at
CIGNA included industry research, forecasting healthcare expenditures,
writing analytical narratives of clients' medical benefit plans, and
identifying cost containment measures. Mr. Vendetti earned his MBA in
Finance and Accounting at Rensselaer Polytechnic Institute, and his BS
degree in Biology at SUNY Binghamton. While at Binghamton, Mr. Vendetti
was pre-med, earned his emergency medical technician certification and
was a member of the Binghamton volunteer ambulance corps. He is also a
member of the Association for Investment Management and Research and the
Healthcare Information and Management Systems Society. Mr. Vendetti has
been a guest speaker on CNNfn, CNN MoneyLine, and a member of investment
panels at various healthcare conferences nationwide. In addition, he
has been quoted in numerous healthcare journals and financial
publications such as BusinessWeek, Investors Business Daily and The Wall
Street Journal. On June 26, 2001, The Wall Street Journal ranked Mr.
Vendetti as one of the best stock-picking analysts in its annual 2000
Best on the Street survey.. Profile
TWST: Anthony, please give us an overview of Maxim Group.Mr. Vendetti: Maxim Group is a full-service investment bank broker-
dealer, and we specialize in small to mid-cap healthcare and